Submission Details
| 510(k) Number | K940682 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 10, 1994 |
| Decision Date | June 21, 1994 |
| Days to Decision | 131 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K940682 is an FDA 510(k) clearance for the AXSYM(TM) QUINIDINE, a Fluorescence Polarization Immunoassay, Carbamazepine (Class II — Special Controls, product code LGI), submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on June 21, 1994, 131 days after receiving the submission on February 10, 1994. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.3645.
| 510(k) Number | K940682 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 10, 1994 |
| Decision Date | June 21, 1994 |
| Days to Decision | 131 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | LGI — Fluorescence Polarization Immunoassay, Carbamazepine |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3645 |